Skip to main content
Premium Trial:

Request an Annual Quote

GVK Renews License for Biomarker Database to FDA

NEW YORK (GenomeWeb News) – Indian contract research organization GVK Bio announced today the extension of its Clinical Biomarker Database (GOBIOM) license to the Biomarker Qualification Group of the US Food and Drug Administration.

The GOBIOM database contains the most recent information on all biomarkers reported in various clinical and preclinical studies. In total, it has data on more than 20,000 biomarkers, including biochemical, genomic, imaging, metabolite, cellular, and physiological markers. Also included are multiple data points "comprising experimental, analytical, clinical, and statistical data with their qualifications under different medical interventions," GVK said.

"The collaboration with the US FDA has helped GVK BIO in developing the safety biomarker content in GOBIOM," Sreeni Devidas, vice president of sales and marketing for informatics at GVK, said in a statement. "The interconnectivity between organ toxicities to the drug, dose and population was developed with equal emphasis on its preclinical qualification. Biomarker analysis tools were integrated into the database in a manner that has facilitated the user to make a comparative analysis between the biomarkers of their interest."

The FDA group originally licensed the GOBIOM database in 2007 and renewed it in April 2011.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.